Now enrolling: the spiriTED study for adults with thyroid eye disease (TED)
This study is evaluating an investigational study drug to see how it works in adults with TED.
To be eligible for the spiriTED study, a person must be:
18 to 75 years of age
Diagnosed with Graves’ disease and TED
Currently experiencing moderate to severe symptoms of TED